SEATTLE--(BUSINESS WIRE)--Data from a multicenter registry of targeted renal therapy (TRT™) in patients at high risk for contrast-induced nephropathy (CIN) – a significant cause of kidney failure and a large unmet market need – were presented at the 32nd Annual Scientific Meeting of the Society of Interventional Radiology (SIR) by Bret N. Wiechmann, M.D., vascular and interventional radiologist, Vascular and Interventional Physicians, North Florida Regional Medical Center, Gainesville.
